Johnson & Johnson
PulseAugur coverage of Johnson & Johnson — every cluster mentioning Johnson & Johnson across labs, papers, and developer communities, ranked by signal.
- 2026-05-22 hiring Johnson & Johnson posted an opening for an Associate Director focused on AI marketing enablement. 来源
1 天有情绪数据
-
Johnson & Johnson seeks AI marketing lead, boosting healthcare operations
Johnson & Johnson is actively seeking an Associate Director for AI marketing enablement, signaling a significant push to integrate AI into its core healthcare operations. This move highlights a broader trend among globa…
-
J&J CEO: US leads biopharma innovation, boosted by AI
Johnson & Johnson's CEO highlights America's leading role in biopharmaceutical innovation, with U.S. companies driving 55% of global R&D and launching most new medicines. Artificial intelligence is accelerating drug dis…
-
Johnson & Johnson completes clinical study for OTTAVA robotic surgical system
Johnson & Johnson has concluded a clinical study for its OTTAVA robotic surgical system. The study focused on the application of AI and robotics within medical science. Further details on the system's performance and im…
-
Johnson & Johnson uses AI to halve drug development analysis time
Johnson & Johnson is leveraging artificial intelligence to significantly speed up its drug development process. The company has reported a dramatic reduction in analysis time, cutting it from 700 hours down to approxima…
-
Palantir市值飙升至4090亿美元，超越营收增长
Palantir Technologies 实现了重要的市场估值，成为全球最有价值的25家公司之一，尽管其收入与其同行相比相对较少。这家国防软件公司报告了其有史以来首次季度营收超过10亿美元，导致其股价在过去一年中飙升了555%。首席执行官 Alex Karp 对这些结果表示自豪，同时也承认了公司备受争议的历史以及关于其相对于财务基本面高市场估值的持续争论。